With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
My previous post about Congressional in-fighting preventing the extension of trade preferences was quickly overtaken by events. To my surprise, the lame-duck Congress hammered out a better-than-expected trade package, though it will likely be passed as part of a bloated catch-all bill that has been thrown together in a process that short-changes transparency and accountability.
It shouldn't matter whether you're conservative or liberal, for globalization or against: Some trade bills are so obviously beneficial and unobjectionable that there's no excuse for letting them languish. This is the case with a raft of measures that would extend trade preferences for poor countries - preferences due to expire at the end of the year.
Yesterday at Carol Lancaster's launch of her new book on Foreign Aid: Diplomacy, Development and Domestic Politics a somewhat confusing exchange took place between Carol and Andrew Natsios, the "commentator" (in quotes because much of what Andrew had to say was pure Andrew) prompted by moderator Sebastian Mallaby's question: "So where do the two of you think levels of U.S.
Policymakers and pundits are still scrambling to decipher what the results of the U.S. midterm elections mean for the U.S.’s role in the world. Caught in the middle of this is the question of global trade.
HIV/AIDS control is now receiving enormous attention in global health circles. This is reason both for celebration and concern. It is reason for celebration because the disease has been neglected in the past and the tide may be turning against this humanitarian crisis. It is reason for concern because there is growing evidence that the extensive focus on this one disease is crowding-out resources and policy-maker attention for the many other causes of death and illness of the poor in the developing world.